Barbara Montico
0000-0001-6783-2969
Publication & Citation Trends
Publications
0 total
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma
Cited by 4
Semantic Scholar
Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion
Cited by 1
Semantic Scholar
Unraveling the role of hypoxia-inducible factors in cutaneous melanoma: from mechanisms to therapeutic opportunities OA
Cited by 3
Semantic Scholar
Abstract 202: Spry1 targeting enhances E-cadherin expression in cutaneous melanoma
Cited by 1
Semantic Scholar
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors OA
Cited by 5
Semantic Scholar
Autophagy in BRAF-mutant cutaneous melanoma: recent advances and therapeutic perspective OA
Cited by 13
Semantic Scholar
Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell-based vaccine efficiency to elicit antitumor immune response in vitro. OA
Cited by 3
Semantic Scholar
Abstract 4806: Spry1 as a potential new hypoxia modulator in cutaneous melanoma
Cited by 0
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(10)
Cancer-related molecular mechanisms research
(9)
Fibroblast Growth Factor Research
(8)
Melanoma and MAPK Pathways
(5)
Cancer, Hypoxia, and Metabolism
(4)
Affiliations
Centro di Riferimento Oncologico
Istituti di Ricovero e Cura a Carattere Scientifico
University of Virginia